🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. Interferon beta-1a

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 mab completed

    1 trial

  2. Isradipine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 small molecule completed

    1 trial

  3. JDtic

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule terminated

    1 trial

  4. KNX100

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  5. Kindolor Tosylate

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 small molecule terminated

    1 trial

  6. L-dopa / carbidopa / entacapone (LCE)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    phase 1 small molecule completed

    1 trial

  7. Lamotrigine Extended Release

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  8. Lenalidomide (CC-5013)

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  9. Levodopa Cyclops®

    BRIGHT MINDS BIOSCIENCES INC.

    Parkinson

    phase 1 other completed

    1 trial

  10. Lidocaine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Heat Effect

    phase 1 small molecule completed

    1 trial

  11. Lifestyle counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Adherence

    phase 1 other completed

    1 trial

  12. Lobeline

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 1 small molecule active

    1 trial

  13. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Related Disorders

    phase 1 small molecule terminated

    1 trial

  14. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 1 small molecule completed

    1 trial

  15. Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  16. Lofexidine (granules for reconstitution)

    BRIGHT MINDS BIOSCIENCES INC.

    Normal Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  17. Lofexidine HCl

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  18. Lofexidine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product

    phase 1 small molecule completed

    1 trial

  19. Lofexidine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Normal Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. Lopinavir/Ritonavir 200 mg/50 mg Film Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  21. Lorcaserin

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  22. MCAM

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule active

    1 trial

  23. MDMA

    BRIGHT MINDS BIOSCIENCES INC.

    MDMA ('Ecstasy')

    phase 1 small molecule completed

    1 trial

  24. MDMA

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolism

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources